Contract research organisation ClinTec International has appointed Dr Harley Simon as chief medical officer and executive vice president of client relations.
He joins the CRO from Merck & Co, where he spent 14 years in various management positions, most recently as executive director of clinical research in the Eastern European, Middle East and Africa, and Asia Pacific regions.
Dr Simon said: “I am very excited at the prospect of joining ClinTec International. I have been interacting with this dynamic company for almost 10 years and have been extremely impressed by its innovative approach, flexibility, customer-centricity and professionalism.
“ClinTec’s organic growth over the last decade has been remarkable, and I look forward to being part of the ongoing expansion in this challenging new role.”
A registered physician in the UK and South Africa, Dr Simon has almost 20 years experience in clinical medicine and clinical research.
In his new role at ClinTec he will report to the CRO’s founder and CEO Dr Rabinder Buttar.
Dr Rabinder Buttar, ClinTec International’s Founder and CEO, said: “As we approach the 20th year of continuous global growth and development at ClinTec International, I am proud to enhance our senior leadership team with an enterprising and high calibre industry professional who is already familiar with, and respects, ClinTec’s culture and values which will remain centre stage as we expand our business.
“Indeed, we are well positioned for the achievement of further global growth for our organisation and I look forward to Dr Simon playing a key role in ClinTec’s bright future.
As CMO and executive vice president, client relations, Dr Simon will be responsible for leading and generating value within ClinTec’s strategic partnerships with its pharmaceutical and biotech clients.